GROUP MEMBERS

DR CHRIS DAVID

Dr Christopher David has a background in biochemistry, regenerative medicine, and nanotoxicology, having gained his BSc in Medical Biochemistry and MSc in Nanomedicine at Swansea University before joining the Department of Molecular and Clinical Pharmacology at the University of Liverpool to undertake his PhD.
His ongoing research investigates biocompatibility and immunological safety of conventional and nanotechnology-enabled medicines as well as cellular therapies to better inform the assessment methodologies used for biologically applied nanotechnologies